MedTrace Logo

Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone

NCT00662181 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2008-04-21

No results posted yet for this study

Summary

A follow-up study on the randomized, controlled, double-blind HIGH: low study. We will examine the participants from the HIGH: low study min. 6 months after finishing the HIGH: low study. We will look at the parameters: quality of life, sugar-metabolism, fat-metabolism, fat-redistribution and cytokines. The study will use the participants control visit, and the only additional examination will be the danish MOS-HIV questionnaire.

Conditions

  • HIV Infections
  • HIV-Associated Lipodystrophy Syndrome

Sponsors & Collaborators

  • Hvidovre University Hospital

    lead OTHER

Principal Investigators

  • Ove Andersen, MD · Klinisk Forskningcenter, Hvidovre Hospital

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2008-10-31
Completion
2009-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00662181 on ClinicalTrials.gov